Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) CFO Greg Zante sold 66,756 shares of the stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $74.69, for a total value of $4,986,005.64. Following the completion of the sale, the chief financial officer now owns 174,854 shares of […]
Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) traded up 0.6% during trading on Monday . The stock traded as high as $76.44 and last traded at $74.74. 1,302,271 shares traded hands during trading, a decline of 77% from the average session volume of 5,546,540 shares. The stock had previously closed at $74.31. […]
StockNews.com upgraded shares of Viking Therapeutics (NASDAQ:VKTX – Free Report) to a sell rating in a report issued on Thursday morning. A number of other equities analysts have also weighed in on the company. Oppenheimer upped their price objective on Viking Therapeutics from $116.00 to $138.00 and gave the stock an outperform rating in a […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) released its quarterly earnings results on Wednesday. The biotechnology company reported ($0.26) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.01, Briefing.com reports. During the same quarter in the previous year, the company posted ($0.25) EPS. Viking Therapeutics Trading Up 7.9 % […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) announced its quarterly earnings data on Wednesday. The biotechnology company reported ($0.26) EPS for the quarter, beating analysts’ consensus estimates of ($0.27) by $0.01, Briefing.com reports. During the same period in the previous year, the company posted ($0.25) earnings per share. Viking Therapeutics Trading Up 0.5 % Shares […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shares traded up 1.8% during mid-day trading on Wednesday following a better than expected earnings announcement. The stock traded as high as $67.78 and last traded at $66.13. 904,840 shares were traded during mid-day trading, a decline of 84% from the average session volume of 5,629,811 shares. […]
Viking Therapeutics (NASDAQ:VKTX – Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported ($0.26) earnings per share for the quarter, topping the consensus estimate of ($0.27) by $0.01, Briefing.com reports. During the same period last year, the company earned ($0.25) EPS. Viking Therapeutics Trading Up 3.3 % NASDAQ:VKTX traded up […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report)’s share price fell 3.6% on Tuesday . The company traded as low as $72.41 and last traded at $73.14. 913,562 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 6,163,342 shares. The stock had previously closed at $75.88. Wall Street […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) fell 3% during mid-day trading on Wednesday . The stock traded as low as $68.30 and last traded at $70.67. 1,604,370 shares traded hands during trading, a decline of 74% from the average session volume of 6,125,949 shares. The stock had previously closed at $72.83. Wall Street […]
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) shares traded up 2% during trading on Wednesday . The stock traded as high as $79.28 and last traded at $78.86. 695,202 shares changed hands during trading, a decline of 89% from the average session volume of 6,382,853 shares. The stock had previously closed at $77.35. Analyst […]